Stockscreener 앱 받기
1.70
5.52%
-0.11
전일 마감가:
$1.81
열려 있는:
$1.81
하루 거래량:
25,831
Relative Volume:
0.76
시가총액:
$39.60M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-6.56%
1개월 성능:
-55.47%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$1.66
$1.955
1주일 범위
$1.66
$2.151
52주 변동 폭
$1.47
$4.00
Advanced Biomed Inc Stock (ADVB) Company Profile
명칭
Advanced Biomed Inc
전화
86-21-20510823
주소
401 RYLAND ST, RENO
ADVB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADVB
Advanced Biomed Inc
|
1.71 | 39.60M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
420.83 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
183.26 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
405.85 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
100.20 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
139.34 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Advanced Biomed Inc 주식(ADVB)의 최신 뉴스
Harbour BioMed Reports Full Year 2024 Financial Results - Yahoo Finance
Mainz enrols first subject in study to evaluate colorectal cancer test - Yahoo Finance
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study - Yahoo Finance
Advanced Instruments to Acquire and Merge with Nova Biomedical - Contract Pharma
Biomedical Engineering Courses: Admission 2025, Fees, Eligibility, Entrance Exams, Syllabus/Subjects, Top Colleges, Career Scope & Salary - Shiksha
Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies - PR Newswire
Advanced Biomed Inc. Completes Successful IPO Launch - TipRanks
Revolutionizing Biomedical Research: Unveiling the Power of Microphysiological Systems with Advanced Assays, Integrated Sensor Technologies, and Real-Time Monitoring - ACS Publications
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga
Red-hot market supports two med-tech IPOs in a day - BioWorld Online
A Dynamic Duo: Travis Stancil and Natella Devitskya Celebrate Five Years of Captivating Performances - The Manila Times
Advanced Biomed Inc. Announces Closing of Initial Public Offering Raising $6.56 Million - Nasdaq
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering - Morningstar
Advanced Biomed prices IPO at $4 per share - MSN
Advanced Biomed Prices 1.6 Million Shares to Raise $6.6 Million in IPO - MarketScreener
OverDrive Appoints Eric Miller to Lead the Company's Data and Information Science Services - The Manila Times
ADVB IPO NewsTaiwanese diagnostics developer Advanced Biomed prices downsized US IPO at the $4 low end - Renaissance Capital
Advanced Biomed Inc. Announces Pricing of Initial Public Offering - GlobeNewswire
This Cancer Detection Biotech Just Priced Its Nasdaq IPOKey Details Inside - StockTitan
Can Mainz Biomed's 82% Detection Rate Technology Revolutionize Colorectal Cancer Prevention? - StockTitan
IPO Roundup: Advanced Biomed, Brag House Holdings and more - MSN
HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies - BioSpace
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development - PR Newswire
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development - GlobeNewswire
Mainz Biomed Launches Major U.S. Study for AI-Powered Colorectal Cancer Detection Test - Stock Titan
Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab - Yahoo Finance
Orchestra BioMed shares get shot in the arm on solid clinical trial data - Mugglehead Magazine
Mainz Biomed Enters Agreement with Quest Diagnostics to Advance ColoAlert Colorectal Cancer Screening Test - Nasdaq
Fluid Biomed Inc. Raises $27 Million USD in Oversubscribed Series A Financing to Advance World’s First Bioabsorbable Polymer-Based Stent To Treat Brain Aneurysms - Business Wire
Advanced Biomedical Material Design to Toxicity - ResearchGate
FBB Biomed partners with Verici Dx to advance research on neurologic diseases - Corridor Business Journal
Thermo Fisher Scientific and Mainz Biomed Partner to Advance Colorectal Cancer Screening Technology - citybuzz -
Mainz Biomed Partners with Thermo Fisher to Advance Colorectal Cancer Screening - Contract Pharma
L&K BIOMED Announces FDA Approval of the BluEX Lumbar Expandable Cage System, Featuring Advanced Surface Technology for Comprehensive Spine Interbody Fusion Options. - Becker's Spine Review
Advanced Biomed dramatically downsizes proposed IPO to $9.4M - MSN
Taiwanese diagnostics developer Advanced Biomed slashes deal size by 92% ahead of $9 million US IPO - renaissancecapital.com
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update - Yahoo Finance
Thermoelectric Materials and Devices for Advanced Biomedical ApplicationsJia2024Small - Wiley Online Library
Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors - PR Newswire
Roche and BARDA: partnering for better brain health - Roche
AskBio and Belief BioMed partner to advance gene therapies - Pharmaceutical Technology
AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies - Bayer
Curi Bio’s Growth Propels Move to Prime Seattle Location to Advance Cutting-Edge Drug Discovery Research - Business Wire
(PDF) Polysaccharide-Based Hydrogels for Advanced Biomedical Engineering Applications - ResearchGate
Polysaccharide-Based Hydrogels for Advanced Biomedical Engineering Applications - ACS Publications
Medical Device Maker Nova Biomedical Is Exploring a Sale - Bloomberg
Genexys BioMed Awarded $320K SBIR Grant to Advance Novel Cystic Fibrosis Gene Therapy - PR Newswire
Biomedical applications of functional hydrogels: Innovative developments, relevant clinical trials and advanced products - ScienceDirect.com
Mainz BioMed Seeks FDA Breakthrough Device Designation for Advanced Colorectal Cancer Test - Proactive financial news
Mainz Biomed seeks FDA’s Breakthrough Devices Designation for advanced colorectal cancer test - News-Medical.Net
NASDAQ – Stock Price, Charts and News Today - BNN Bloomberg
Advanced Biomed Inc (ADVB) 재무 분석
Advanced Biomed Inc (ADVB)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.05%
0.35%
자본화:
|
볼륨(24시간):